Pfizer has been struggling for several years. The company's pipeline could help it turn things around.

Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens gains in 2026 after a 16.39% rise in 2025, with AI leaders li

Cantor Fitzgerald Investment Advisors L.P. increased its stake in shares of Pfizer Inc. (NYSE: PFE) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 547,184 shares of the biopharmaceutical company's stock after buying an additional 25,090 shares

Ares Capital offers an especially juicy dividend. Energy Transfer has an impressive track record of increasing its distribution each quarter.

Pfizer's stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live with the coronavirus, and Pfizer's stock has plunged as a result.

Pfizer (PFE) and GlaxoSmithKline (GSK) are among the top drugmakers planning price increases for hundreds of branded medicines in the U.S. next year, according

The market of 2025 will be remembered for its extremes. While investors poured billions into technology sector giants and companies manufacturing weight-loss drugs, traditional pharmaceutical leaders were left in the cold.

Pfizer (PFE, Financials) and GSK (GSK, Financials) are leading a new round of price adjustments set to take effect in early 2026, with data from healthcare anal

Generating meaningful dividend income from modest capital requires disciplined stock selection and a clear mathematical framework. An allocation of $2,670 distributed equally across three carefully vetted ultra-high-yield securities, each offering yields exceeding 6%, can reasonably generate approximately $300 in annual dividend income.

Both companies have faced some headwinds recently, but the core businesses and dividend payouts remain strong. Blackstone is the top alternative asset manager in the world and operates as a premier global investment firm for institutional and individual investors.